Exon 18 Mutations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Insights into how the UNICORN study, which assessed osimertinib, is impacting treatment decisions for uncommon EGFR mutations, and other ongoing trials shedding light on effective treatments for this patient population.

Precision medicineBiomarker testingNon small cell lung cancerLung cancerUnicorn studyUnicorn trialUncommon egfr mutationsExon 20 insertionsIntracranial diseaseExon 18 mutationsExon 21 mutations